$CGCF·8-K

Cartesian Growth Corp IV · Jun 30, 8:12 AM ET

Compare

Cartesian Growth Corp IV 8-K

Research Summary

AI-generated summary

Updated

Cartesian Growth Corp IV Completes IPO, Raises $275M; Board Appointments

What Happened Cartesian Growth Corp IV announced the closing of its initial public offering after its Form S-1 was declared effective on June 24, 2026. On June 26, 2026, the company sold 27,500,000 units (including a 2,500,000-unit partial over-allotment) at $10.00 per unit, generating gross proceeds of $275,000,000. Each Unit consists of one Class A ordinary share and one‑third of a redeemable warrant (full warrant exercise price $11.50). Simultaneously, the company completed a private placement of 2,500,000 warrants (937,500 to the Sponsor; 1,562,500 to Cantor) at $2.00 each, raising $5,000,000. A total of $275,000,000 of net proceeds was placed in a trust account with Continental Stock Transfer & Trust Company as trustee.

Key Details

  • Offering: 27,500,000 Units at $10.00 each (includes 2,500,000 Units from underwriters’ partial over-allotment); gross proceeds $275,000,000.
  • Warrants: Each Unit includes one‑third of a Warrant; full Warrant exercise price $11.50 (subject to adjustment).
  • Private Placement: 937,500 warrants to CGC IV Sponsor LLC and 1,562,500 to Cantor Fitzgerald & Co. at $2.00 each; gross proceeds $5,000,000; Private Placement Warrants carry transfer restrictions and registration rights.
  • Corporate actions: Amended and restated memorandum and articles filed (authorizing up to 200,000,000 Class A shares, 20,000,000 Class B shares, and 1,000,000 preference shares); three directors (Yongchen Lu, Monica Roma Wilson, Eduardo Agustin Ojea Quintana) appointed effective June 24, 2026; indemnity agreements entered for directors/officers.

Why It Matters This 8-K confirms Cartesian Growth Corp IV has completed its public offering and placed the offering proceeds into a trustee‑controlled trust account, a key safeguard for public shareholders pending the company’s initial business combination. Investors should note the size of the raise ($275M in trust), the warrant terms (exercise price $11.50), the private placement that issued additional warrants to the sponsor and underwriter, and recent board additions—factors that affect governance, potential dilution, and the company’s path to a business combination.

Loading document...